Gen Kanayama, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anabolic Agents | 32 | 2022 | 247 | 6.610 |
Why?
|
Androgens | 23 | 2024 | 1279 | 4.260 |
Why?
|
Substance-Related Disorders | 29 | 2022 | 4320 | 2.520 |
Why?
|
Testosterone Congeners | 9 | 2022 | 61 | 2.060 |
Why?
|
Weight Lifting | 10 | 2020 | 126 | 1.970 |
Why?
|
Body Image | 8 | 2020 | 626 | 1.900 |
Why?
|
Body Dysmorphic Disorders | 4 | 2022 | 242 | 1.860 |
Why?
|
Steroids | 7 | 2024 | 923 | 1.450 |
Why?
|
Hypogonadism | 6 | 2022 | 790 | 1.430 |
Why?
|
Doping in Sports | 9 | 2018 | 62 | 1.260 |
Why?
|
Antisocial Personality Disorder | 2 | 2018 | 226 | 0.680 |
Why?
|
Performance-Enhancing Substances | 3 | 2017 | 29 | 0.650 |
Why?
|
Conduct Disorder | 3 | 2018 | 239 | 0.600 |
Why?
|
Athletes | 4 | 2018 | 1095 | 0.490 |
Why?
|
Testosterone | 8 | 2024 | 2443 | 0.470 |
Why?
|
Tendon Injuries | 1 | 2015 | 325 | 0.400 |
Why?
|
Psychoses, Substance-Induced | 2 | 2010 | 95 | 0.380 |
Why?
|
Behavioral Symptoms | 1 | 2012 | 181 | 0.360 |
Why?
|
Cultural Characteristics | 1 | 2011 | 252 | 0.340 |
Why?
|
Public Health | 3 | 2018 | 2645 | 0.330 |
Why?
|
Culture | 1 | 2012 | 624 | 0.300 |
Why?
|
Social Perception | 1 | 2011 | 430 | 0.290 |
Why?
|
Marijuana Abuse | 3 | 2008 | 410 | 0.280 |
Why?
|
Photic Stimulation | 1 | 2012 | 1981 | 0.270 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2011 | 1959 | 0.270 |
Why?
|
Men | 1 | 2006 | 64 | 0.260 |
Why?
|
Infertility, Male | 1 | 2008 | 399 | 0.250 |
Why?
|
Women | 1 | 2006 | 226 | 0.250 |
Why?
|
Quality of Life | 3 | 2024 | 13165 | 0.220 |
Why?
|
Attitude to Health | 2 | 2011 | 2029 | 0.210 |
Why?
|
Cognition Disorders | 2 | 2015 | 3972 | 0.200 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2003 | 167 | 0.200 |
Why?
|
Dietary Supplements | 3 | 2012 | 3349 | 0.190 |
Why?
|
Attitude | 1 | 2006 | 771 | 0.190 |
Why?
|
Space Perception | 1 | 2004 | 464 | 0.190 |
Why?
|
Cytoskeletal Proteins | 2 | 1997 | 1349 | 0.180 |
Why?
|
Self Medication | 2 | 2011 | 114 | 0.180 |
Why?
|
Male | 43 | 2022 | 354773 | 0.180 |
Why?
|
Gender Identity | 1 | 2006 | 694 | 0.180 |
Why?
|
Cardiomyopathies | 2 | 2011 | 1918 | 0.180 |
Why?
|
Nonprescription Drugs | 1 | 2001 | 117 | 0.180 |
Why?
|
Athletic Performance | 2 | 2018 | 99 | 0.170 |
Why?
|
Psychophysiologic Disorders | 1 | 2001 | 222 | 0.170 |
Why?
|
Competitive Behavior | 1 | 2019 | 78 | 0.160 |
Why?
|
Humans | 52 | 2024 | 752320 | 0.160 |
Why?
|
Testis | 1 | 2022 | 794 | 0.160 |
Why?
|
Memory, Short-Term | 1 | 2004 | 965 | 0.150 |
Why?
|
Adult | 32 | 2020 | 216953 | 0.150 |
Why?
|
Mental Disorders | 3 | 2018 | 6708 | 0.150 |
Why?
|
Sports | 3 | 2018 | 690 | 0.140 |
Why?
|
Neurosecretory Systems | 1 | 2018 | 223 | 0.140 |
Why?
|
Psychopathology | 1 | 2019 | 418 | 0.130 |
Why?
|
Interviews as Topic | 2 | 2015 | 2619 | 0.130 |
Why?
|
Cardiovascular Diseases | 3 | 2020 | 15480 | 0.120 |
Why?
|
Brain Injuries | 2 | 1997 | 2043 | 0.120 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 4876 | 0.120 |
Why?
|
Data Interpretation, Statistical | 2 | 2018 | 2689 | 0.120 |
Why?
|
Motor Cortex | 3 | 2008 | 985 | 0.120 |
Why?
|
Rupture | 1 | 2015 | 442 | 0.110 |
Why?
|
Behavior, Addictive | 1 | 2019 | 461 | 0.110 |
Why?
|
Motor Skills | 2 | 2008 | 521 | 0.110 |
Why?
|
Mood Disorders | 1 | 2020 | 1109 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2017 | 2109 | 0.110 |
Why?
|
Self Concept | 2 | 2011 | 1026 | 0.110 |
Why?
|
Fitness Centers | 1 | 2012 | 13 | 0.100 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 25477 | 0.100 |
Why?
|
Atherosclerosis | 1 | 2008 | 3458 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2185 | 0.100 |
Why?
|
Antidepressive Agents | 3 | 2011 | 2878 | 0.100 |
Why?
|
Depression | 2 | 2011 | 7930 | 0.100 |
Why?
|
Psychosomatic Medicine | 1 | 2012 | 70 | 0.100 |
Why?
|
Young Adult | 7 | 2018 | 57766 | 0.100 |
Why?
|
tau Proteins | 2 | 2019 | 2048 | 0.090 |
Why?
|
History, 21st Century | 1 | 2017 | 1560 | 0.090 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2010 | 6002 | 0.090 |
Why?
|
Sports Medicine | 1 | 2012 | 233 | 0.090 |
Why?
|
Amphetamine-Related Disorders | 1 | 2010 | 74 | 0.080 |
Why?
|
Comorbidity | 3 | 2018 | 10454 | 0.080 |
Why?
|
History, 20th Century | 1 | 2017 | 2762 | 0.080 |
Why?
|
Adolescent | 10 | 2015 | 86875 | 0.080 |
Why?
|
Prevalence | 5 | 2018 | 15445 | 0.080 |
Why?
|
Behavior, Animal | 1 | 1996 | 1853 | 0.080 |
Why?
|
Middle Aged | 15 | 2020 | 216804 | 0.080 |
Why?
|
Methamphetamine | 1 | 2010 | 158 | 0.070 |
Why?
|
Crime | 2 | 2021 | 198 | 0.070 |
Why?
|
Methandrostenolone | 1 | 2006 | 5 | 0.070 |
Why?
|
Erectile Dysfunction | 1 | 2011 | 453 | 0.070 |
Why?
|
Cocaine-Related Disorders | 1 | 2009 | 458 | 0.070 |
Why?
|
Reaction Time | 1 | 2012 | 2069 | 0.070 |
Why?
|
Opioid-Related Disorders | 3 | 2009 | 2105 | 0.070 |
Why?
|
Cricetinae | 1 | 2009 | 2425 | 0.070 |
Why?
|
Brain | 3 | 2019 | 26838 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2230 | 0.070 |
Why?
|
Coronary Vessels | 1 | 2017 | 3080 | 0.060 |
Why?
|
Human Growth Hormone | 1 | 2010 | 635 | 0.060 |
Why?
|
Amyloid beta-Peptides | 1 | 2019 | 3788 | 0.060 |
Why?
|
Goals | 1 | 2010 | 698 | 0.060 |
Why?
|
Neurofilament Proteins | 2 | 1997 | 319 | 0.060 |
Why?
|
Dementia | 1 | 2019 | 2589 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3808 | 0.060 |
Why?
|
Electroconvulsive Therapy | 1 | 2010 | 501 | 0.060 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2008 | 694 | 0.060 |
Why?
|
Stereotyping | 1 | 2006 | 238 | 0.060 |
Why?
|
Long-Term Care | 1 | 2008 | 622 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2011 | 12906 | 0.060 |
Why?
|
Heterosexuality | 1 | 2006 | 291 | 0.060 |
Why?
|
Drug Interactions | 1 | 2008 | 1420 | 0.060 |
Why?
|
Somatoform Disorders | 1 | 2006 | 421 | 0.050 |
Why?
|
Memory | 1 | 2012 | 2177 | 0.050 |
Why?
|
Rats, Wistar | 2 | 1997 | 1861 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2017 | 21804 | 0.050 |
Why?
|
Attention | 1 | 2012 | 2379 | 0.050 |
Why?
|
Phosphorylation | 3 | 2019 | 8325 | 0.050 |
Why?
|
Systole | 2 | 2017 | 934 | 0.050 |
Why?
|
Diastole | 2 | 2017 | 779 | 0.050 |
Why?
|
Health Surveys | 2 | 2013 | 3987 | 0.050 |
Why?
|
Ephedrine | 1 | 2001 | 52 | 0.050 |
Why?
|
Androstenedione | 1 | 2001 | 131 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 2 | 1997 | 1083 | 0.050 |
Why?
|
Central Nervous System Stimulants | 1 | 2010 | 1159 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2011 | 2065 | 0.050 |
Why?
|
Risk-Taking | 1 | 2006 | 990 | 0.050 |
Why?
|
Alzheimer Disease | 3 | 2019 | 8409 | 0.050 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.050 |
Why?
|
Sex Factors | 2 | 2006 | 10410 | 0.050 |
Why?
|
Internet | 1 | 2013 | 3057 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2020 | 10789 | 0.040 |
Why?
|
Narcotics | 1 | 2001 | 336 | 0.040 |
Why?
|
Depressive Disorder, Major | 2 | 2010 | 4694 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2015 | 36037 | 0.040 |
Why?
|
Cohort Studies | 3 | 2020 | 40785 | 0.040 |
Why?
|
Models, Statistical | 1 | 2013 | 5052 | 0.040 |
Why?
|
Discrimination Learning | 1 | 2000 | 277 | 0.040 |
Why?
|
Animals | 7 | 2019 | 167131 | 0.040 |
Why?
|
Aggression | 1 | 2003 | 747 | 0.040 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2003 | 624 | 0.040 |
Why?
|
Time Factors | 4 | 2017 | 39867 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2003 | 2925 | 0.040 |
Why?
|
HSP72 Heat-Shock Proteins | 1 | 1997 | 41 | 0.040 |
Why?
|
Functional Laterality | 1 | 2004 | 2264 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6503 | 0.040 |
Why?
|
Incidence | 1 | 2015 | 21021 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15675 | 0.040 |
Why?
|
Echocardiography, Doppler | 2 | 2011 | 900 | 0.030 |
Why?
|
Anorexia Nervosa | 1 | 2006 | 1356 | 0.030 |
Why?
|
Axonal Transport | 1 | 1997 | 178 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1873 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3124 | 0.030 |
Why?
|
Female | 13 | 2020 | 386035 | 0.030 |
Why?
|
Republic of Korea | 1 | 2018 | 542 | 0.030 |
Why?
|
Gels | 2 | 2010 | 416 | 0.030 |
Why?
|
Visual Perception | 1 | 2004 | 1383 | 0.030 |
Why?
|
Gyrus Cinguli | 2 | 2015 | 1110 | 0.030 |
Why?
|
Risk Factors | 5 | 2019 | 73071 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2009 | 7740 | 0.030 |
Why?
|
Violence | 1 | 2021 | 922 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2003 | 1243 | 0.030 |
Why?
|
Inositol | 1 | 2015 | 215 | 0.030 |
Why?
|
Hypertrophy | 1 | 2015 | 563 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 1997 | 799 | 0.030 |
Why?
|
Dendrites | 1 | 1996 | 477 | 0.030 |
Why?
|
Anisotropy | 1 | 2016 | 1287 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 1997 | 11027 | 0.030 |
Why?
|
Neuropsychological Tests | 3 | 2015 | 6967 | 0.030 |
Why?
|
Social Adjustment | 1 | 2015 | 632 | 0.030 |
Why?
|
Affect | 1 | 2000 | 1477 | 0.030 |
Why?
|
Bullying | 1 | 2015 | 212 | 0.030 |
Why?
|
Age Factors | 1 | 2009 | 18265 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1376 | 0.030 |
Why?
|
Glutamine | 1 | 2015 | 572 | 0.030 |
Why?
|
Biomedical Research | 1 | 2007 | 3374 | 0.030 |
Why?
|
Amygdala | 2 | 2015 | 1337 | 0.020 |
Why?
|
Lisinopril | 1 | 2011 | 54 | 0.020 |
Why?
|
Nerve Degeneration | 1 | 1996 | 741 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2004 | 3204 | 0.020 |
Why?
|
Odds Ratio | 1 | 2003 | 9648 | 0.020 |
Why?
|
Furosemide | 1 | 2011 | 170 | 0.020 |
Why?
|
Consumer Health Information | 1 | 2013 | 209 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7402 | 0.020 |
Why?
|
Rats | 2 | 1997 | 23748 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2010 | 222 | 0.020 |
Why?
|
Double-Blind Method | 3 | 2011 | 12337 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2012 | 79168 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1160 | 0.020 |
Why?
|
United States | 4 | 2013 | 71280 | 0.020 |
Why?
|
Logistic Models | 1 | 2003 | 13243 | 0.020 |
Why?
|
Israel | 1 | 2011 | 720 | 0.020 |
Why?
|
Diuretics | 1 | 2011 | 609 | 0.020 |
Why?
|
Massachusetts | 1 | 2001 | 8664 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2019 | 3054 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 8974 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2011 | 6494 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3281 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2010 | 1571 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2380 | 0.020 |
Why?
|
Motor Activity | 1 | 1996 | 2677 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1492 | 0.020 |
Why?
|
Health Education | 1 | 2012 | 1048 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2017 | 4524 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8554 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2011 | 743 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2010 | 807 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2776 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2010 | 1505 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2474 | 0.020 |
Why?
|
Echocardiography | 1 | 2017 | 4945 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1547 | 0.010 |
Why?
|
Fibroblasts | 1 | 1995 | 4060 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2846 | 0.010 |
Why?
|
Neural Pathways | 1 | 2015 | 3034 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2350 | 0.010 |
Why?
|
Recurrence | 1 | 1996 | 8428 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8444 | 0.010 |
Why?
|
Stroke Volume | 1 | 2017 | 5430 | 0.010 |
Why?
|
Hippocampus | 1 | 1996 | 3710 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2000 | 5069 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1912 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 23717 | 0.010 |
Why?
|
Calcium | 1 | 1995 | 5669 | 0.010 |
Why?
|
Health | 1 | 2004 | 394 | 0.010 |
Why?
|
Physical Fitness | 1 | 2004 | 725 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5833 | 0.010 |
Why?
|
Drug Tolerance | 1 | 2001 | 370 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1996 | 5740 | 0.010 |
Why?
|
Trust | 1 | 2004 | 519 | 0.010 |
Why?
|
Naloxone | 1 | 2001 | 362 | 0.010 |
Why?
|
Health Personnel | 1 | 2012 | 3253 | 0.010 |
Why?
|
Morphine | 1 | 2001 | 649 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2010 | 64333 | 0.010 |
Why?
|
Narcotic Antagonists | 1 | 2001 | 566 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1996 | 17972 | 0.010 |
Why?
|
Facial Expression | 1 | 2000 | 511 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2010 | 3060 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2001 | 2315 | 0.010 |
Why?
|
Calcimycin | 1 | 1995 | 212 | 0.010 |
Why?
|
Hot Temperature | 1 | 2001 | 1433 | 0.010 |
Why?
|
Vasopressins | 1 | 1995 | 368 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13412 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2010 | 19901 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2004 | 3968 | 0.010 |
Why?
|
Pain Measurement | 1 | 2001 | 3488 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2000 | 2196 | 0.010 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 1995 | 1101 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 38973 | 0.000 |
Why?
|
Smoking | 1 | 2004 | 8998 | 0.000 |
Why?
|
Aged | 3 | 2010 | 166336 | 0.000 |
Why?
|
Cell Cycle | 1 | 1995 | 2930 | 0.000 |
Why?
|
Heart Failure | 1 | 2010 | 11713 | 0.000 |
Why?
|
Analgesics, Opioid | 1 | 2001 | 3695 | 0.000 |
Why?
|
Brain Mapping | 1 | 2000 | 6618 | 0.000 |
Why?
|
Family | 1 | 1995 | 3166 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1995 | 18932 | 0.000 |
Why?
|